Article
Real-world Omalizumab and Mepolizumab treated difficult asthma phenotypes and their clinical outcomes.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology - 1 Aug 2021
Fong Wei Chern Gavin, Azim Adnan, Knight Deborah, Mistry Heena, Freeman Anna, Felongco Mae, Kyyaly Aref, Harvey Matthew, Dennison Patrick, Zhang Hongmei, Howarth Peter, Arshad Syed Hasan, Kurukulaaratchy Ramesh J
Abstract excerpt
BACKGROUND: Omalizumab and Mepolizumab are biologic drugs with proven efficacy in clinical trials. However, a better understanding of their real-world effectiveness in severe asthma management is needed. OBJECTIVES: To better understand the real-world effectiveness of Omalizumab and Mepolizumab, elucidate the clinical phenotypes of patients treated with these drugs, identify baseline characteristics associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.